The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

Sleep apnea, a condition that disrupts breathing during sleep, affects millions of people worldwide, especially adults over ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

An estimated 39 million American adults suffer from obstructive sleep apnea, a condition in which the upper airway is blocked while sleeping.

Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty of people struggle with symptoms like loud snoring, daytime sleepiness, and morning ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

“It’s important to understand OSA symptoms and know that treatments ... continue experiencing a benefit for sleep apnea.” At least 25 million adults in the U.S. have sleep apnea, according ...